NCT00239590View on ClinicalTrials.gov

Testosterone and Myocardial Perfusion in Coronary Heart Disease (CHD)

PHASE2CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

June 30, 2001

Primary Completion Date

April 24, 2004

Study Completion Date

April 24, 2004

Conditions
Coronary Heart Disease
Interventions
DRUG

Testosterone undecanoate

Licensed for androgen deficiency

Trial Locations (1)

SW3 6NP

Royal Brompton & Harefield NHS Trust, London

Sponsors

Collaborators (1)

Organon
All Listed Sponsors
collaborator

Organon

INDUSTRY

lead

Imperial College London

OTHER

NCT00239590 - Testosterone and Myocardial Perfusion in Coronary Heart Disease (CHD) | Biotech Hunter | Biotech Hunter